News

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...
GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.
Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...
A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...
The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...
See how GLP-1 drugs reduce heart and kidney complications in MGUS and diabetes—explore the clinical evidence. Keep reading!
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 months ...